Filing Flows › Comparisons › XENE vs ETST
Xenon Pharmaceuticals vs Earth Science Tech: XENE and ETST compared
Xenon Pharmaceuticals is the larger company: $7.5M of revenue in its latest quarter (Q1 2025) against $7.3M for Earth Science Tech (Q2 FY27). Earth Science Tech is more profitable, with an operating margin of 15.2% against -969.8%.
Where the money goes: XENE and ETST
Xenon Pharmaceuticals (XENE) · Q1 2025
Xenon Pharmaceuticals, Q1 2025: revenue $7.5M, operating margin -969.8%, net loss $65.0M, operating cash flow −$61.7M. The chart follows the revenue to costs, profit and cash.
Earth Science Tech (ETST) · Q2 FY27
Earth Science Tech, Q2 FY27: revenue $7.3M (-19% year over year), operating margin 15.2%, net earnings $831K, operating cash flow $138K. The chart follows the revenue to costs, profit and cash.
| Xenon Pharmaceuticals (XENE) | Earth Science Tech (ETST) | |
|---|---|---|
| Latest quarter | Q1 2025 | Q2 FY27 |
| Revenue | $7.5M | $7.3M |
| Revenue growth, Y/Y | — | -19% |
| Gross margin | — | 69.3% |
| Operating margin | -969.8% | 15.2% |
| Net earnings | −$65.0M | $831K |
| Net margin | -867.3% | 11.4% |
| Operating cash flow | −$61.7M | $138K |
| Market value | $3.6B | — |
| Analysts’ mean target | $71.75 | — |
Questions
Which is bigger, Xenon Pharmaceuticals or Earth Science Tech?
Xenon Pharmaceuticals is the larger company: $7.5M of revenue in its latest quarter (Q1 2025) against $7.3M for Earth Science Tech (Q2 FY27).
Is Xenon Pharmaceuticals or Earth Science Tech growing faster?
Earth Science Tech is more profitable, with an operating margin of 15.2% against -969.8%.
More: Xenon Pharmaceuticals earnings · how Xenon Pharmaceuticals makes money · Earth Science Tech earnings · how Earth Science Tech makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed May 12, 2025; 10-Q filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.